Frederiksberg Hospital — Clinical Trial Site

14 Registered trials

4 Currently recruiting

Organisation

Frederiksberg Hospital

Location

Frederiksberg, Denmark

Identifier

ORG-100028217

Address

Nordre Fasanvej 57, 1st Floor Entrance 2, 2000, Denmark

Departments

Afd. Y4
Cardiology/Department of Biomedicine
Department of Cardiology
Department of Rheumatology
GCP
Hjertemedicinsk afdeling
Klinik for Led- og Bindevævssygdomme
Lab of Neuropsychiatry
N/A
Parker Instituttet
Psychiatric Centre Copenhagen

Clinical trials at this site (14)

Search interface

Can treatment with tirzepatide reduce alcohol intake in individuals diagnosed with schizophrenia and alcohol use disorder (DUALPSYCHIATRY) Recruiting

2024-518608-28-00 Schizophrenia and Alcohol Use Disorder 4 2025-05-01
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-experienced Participants with Active Psoriatic Arthritis Recruiting

2024-517284-23-00 Active Psoriatic Arthritis 5 2025-04-23
DAPHNE Recruiting

2024-510746-14-00 Axial Spondyloarthritis 6 2024-08-28
Ebastine in combination with docetaxel or as a treatment for metastatic castration-resistant prostate cancer Recruiting

2024-518035-11-01 metastatic castration-resistant prostate cancer (mCRPC) 4 2024-06-02
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-naïve Participants with Active Psoriatic Arthritis Ended

2023-509239-19-00 Active Psoriatic Arthritis 5 2025-04-03
A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants with Severe Hypertriglyceridemia (SHTG) Ended

2022-501999-26-00 Severe Hypertriglyceridemia (SHTG) 5 2023-07-12
Guselkumab versus Placebo for the Treatment of Psoriatic Arthritis Axial Disease in Bio-naive Participants Ended

2023-504716-15-00 Psoriatic Arthritis 6 2021-08-06
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Respo… Ended

2023-505477-33-00 Psoriatic Arthritis 5 2019-06-18
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or … Ended

2023-505478-14-00 Psoriatic Arthritis 5 2019-05-09
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
SEMALCO Ended

2023-503371-25-00 Alcohol Use Disorder 4 2023-06-08
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia. Ended

2024-510696-38-00 Severe Hypertriglyceridemia. 5 2022-03-08
A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICKHCM (MY… Ended

2022-502858-14-00 Hypertrophic cardiomyopathy 5 2019-09-05